TARPLIN, DOWNS & YOUNG, LLC

Lobbying for AMNEAL PHARMACEUTICALS, INC. · Pharmaceutical company

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · New Jersey · House · Senate · $60,000.00 income · posted Oct 16, 2025

Lobbying activity 1

Health Issues

drug shortages, critical medicines limited to antibiotics and antimicrobials

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.